133 related articles for article (PubMed ID: 31634715)
1. Implication of the SH3TC2 gene in Charcot-Marie-Tooth disease associated with deafness and/or scoliosis: Illustration with four new pathogenic variants.
Lerat J; Magdelaine C; Lunati A; Dzugan H; Dejoie C; Rego M; Beze Beyrie P; Bieth E; Calvas P; Cintas P; Delaubrier A; Demurger F; Gilbert-Dussardier B; Goizet C; Journel H; Laffargue F; Magy L; Taithe F; Toutain A; Urtizberea JA; Sturtz F; Lia AS
J Neurol Sci; 2019 Nov; 406():116376. PubMed ID: 31634715
[TBL] [Abstract][Full Text] [Related]
2. Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Piscosquito G; Saveri P; Magri S; Ciano C; Gandioli C; Morbin M; Bella DD; Moroni I; Taroni F; Pareyson D
J Peripher Nerv Syst; 2016 Sep; 21(3):142-9. PubMed ID: 27231023
[TBL] [Abstract][Full Text] [Related]
3. Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum.
Kontogeorgiou Z; Nikolaou K; Kartanou C; Breza M; Panas M; Karadima G; Koutsis G
J Peripher Nerv Syst; 2019 Mar; 24(1):125-130. PubMed ID: 30653784
[TBL] [Abstract][Full Text] [Related]
4. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy.
Houlden H; Laura M; Ginsberg L; Jungbluth H; Robb SA; Blake J; Robinson S; King RH; Reilly MM
Neuromuscul Disord; 2009 Apr; 19(4):264-9. PubMed ID: 19272779
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of Patients with
Nagappa M; Sharma S; Govindaraj P; Chickabasaviah YT; Siram R; Shroti A; Seshagiri DV; Debnath M; Sinha S; Bindu PS; Taly AB
Neurol India; 2023; 71(5):940-945. PubMed ID: 37929431
[TBL] [Abstract][Full Text] [Related]
6. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.
Azzedine H; Ravisé N; Verny C; Gabrëels-Festen A; Lammens M; Grid D; Vallat JM; Durosier G; Senderek J; Nouioua S; Hamadouche T; Bouhouche A; Guilbot A; Stendel C; Ruberg M; Brice A; Birouk N; Dubourg O; Tazir M; LeGuern E
Neurology; 2006 Aug; 67(4):602-6. PubMed ID: 16924012
[TBL] [Abstract][Full Text] [Related]
7. Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients.
Sun B; He ZQ; Li YR; Bai JM; Wang HR; Wang HF; Cui F; Yang F; Huang XS
Acta Neurol Belg; 2022 Oct; 122(5):1169-1175. PubMed ID: 33587240
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.
Lee AJ; Nam SH; Park JM; Kanwal S; Choi YJ; Lee HJ; Lee KS; Lee JE; Park JS; Choi BO; Chung KW
J Hum Genet; 2019 Sep; 64(9):961-965. PubMed ID: 31227790
[TBL] [Abstract][Full Text] [Related]
9. High frequency of SH3TC2 mutations in Czech HMSN I patients.
Laššuthová P; Mazanec R; Vondráček P; Sišková D; Haberlová J; Sabová J; Seeman P
Clin Genet; 2011 Oct; 80(4):334-45. PubMed ID: 21291453
[TBL] [Abstract][Full Text] [Related]
10. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
Schiza N; Georgiou E; Kagiava A; Médard JJ; Richter J; Tryfonos C; Sargiannidou I; Heslegrave AJ; Rossor AM; Zetterberg H; Reilly MM; Christodoulou C; Chrast R; Kleopa KA
Brain; 2019 May; 142(5):1227-1241. PubMed ID: 30907403
[TBL] [Abstract][Full Text] [Related]
11. Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.
Yuan JH; Hashiguchi A; Okamoto Y; Yoshimura A; Ando M; Shiomi K; Saito K; Takahashi M; Ichinose K; Ohmichi T; Ichikawa K; Tadashi A; Takigawa H; Shibayama H; Takashima H
J Hum Genet; 2018 Mar; 63(3):281-287. PubMed ID: 29321516
[TBL] [Abstract][Full Text] [Related]
12. Genetic Landscape of
Shchagina O; Murtazina A; Chausova P; Orlova M; Dadali E; Kurbatov S; Kutsev S; Polyakov A
Front Genet; 2024; 15():1381915. PubMed ID: 38903759
[TBL] [Abstract][Full Text] [Related]
13. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system.
Arnaud E; Zenker J; de Preux Charles AS; Stendel C; Roos A; Médard JJ; Tricaud N; Kleine H; Luscher B; Weis J; Suter U; Senderek J; Chrast R
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17528-33. PubMed ID: 19805030
[TBL] [Abstract][Full Text] [Related]
14. Screening for
Zhao X; Jiang MM; Yan YZ; Liu L; Xie YZ; Li XB; Hu ZM; Zi XH; Xia K; Tang BS; Zhang RX
Chin Med J (Engl); 2018 Jan; 131(2):151-155. PubMed ID: 29336362
[TBL] [Abstract][Full Text] [Related]
15. Clinical, in silico, and experimental evidence for pathogenicity of two novel splice site mutations in the SH3TC2 gene.
Laššuthová P; Gregor M; Sarnová L; Machalová E; Sedláček R; Seeman P
J Neurogenet; 2012 Sep; 26(3-4):413-20. PubMed ID: 22950825
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations in SH3TC2 in a young Japanese girl with Charcot-Marie-Tooth disease type 4C.
Ichikawa K; Numasawa K; Takeshita S; Hashiguchi A; Takashima H
Pediatr Int; 2016 Nov; 58(11):1252-1254. PubMed ID: 27882734
[TBL] [Abstract][Full Text] [Related]
17. Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history.
Rehbein T; Wu TT; Treidler S; Pareyson D; Lewis R; Yum SW; McCray BA; Ramchandren S; Burns J; Li J; Finkel RS; Scherer SS; Zuchner S; Shy ME; Reilly MM; Herrmann DN
Brain; 2023 Sep; 146(9):3826-3835. PubMed ID: 36947133
[TBL] [Abstract][Full Text] [Related]
18. Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster.
Gosselin I; Thiffault I; Tétreault M; Chau V; Dicaire MJ; Loisel L; Emond M; Senderek J; Mathieu J; Dupré N; Vanasse M; Puymirat J; Brais B
Neuromuscul Disord; 2008 Jun; 18(6):483-92. PubMed ID: 18511281
[TBL] [Abstract][Full Text] [Related]
19. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.
Georgiou E; Kagiava A; Sargiannidou I; Schiza N; Stavrou M; Richter J; Tryfonos C; Heslegrave A; Zetterberg H; Christodoulou C; Kleopa KA
Mol Ther; 2023 Nov; 31(11):3290-3307. PubMed ID: 37641403
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Yger M; Stojkovic T; Tardieu S; Maisonobe T; Brice A; Echaniz-Laguna A; Alembik Y; Girard S; Cazeneuve C; Leguern E; Dubourg O
J Peripher Nerv Syst; 2012 Mar; 17(1):112-22. PubMed ID: 22462672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
